Challenges and Opportunities for Data Reuse Ronald Cornet, PhD Dept. of Medical Informatics Academic Medical Center – University of Amsterdam.

Slides:



Advertisements
Similar presentations
Conducting the Community Analysis. What is a Community Analysis?  Includes market research and broader analysis of community assets and challenges 
Advertisements

Supporting National e-Health Roadmaps WHO-ITU-WB joint effort WSIS C7 e-Health Facilitation Meeting 13 th May 2010 Hani Eskandar ICT Applications, ITU.
Health Services Research Howard Bailit, DMD, PhD University of Connecticut Dental Informatics and Dental Research Conference National Institutes of Health.
Criteria For Approval 45 CFR CFR Minimized risks Reasonable risk/benefit ratio Equitable subject selection Informed consent process Informed.
HIPAA HIPAA Health Insurance Portability and Accountability Act of 1996.
Health Insurance Portability Accountability Act of 1996 HIPAA for Researchers: IRB Related Issues HSC USC IRB.
Obtaining Informed Consent: 1. Elements Of Informed Consent 2. Essential Information For Prospective Participants 3. Obligation for investigators.
Conflict and Consent: Managing Disclosure in Human Subjects Research University of Miami Human Subjects Research Office Conflict of Interest Symposium.
Health Line of Business Revised Health Domains January 26, 2005 Outcomes / Domains have been revised.
HSA 171 CAR. Health care Systems 1436/ 6/30  The Means by Which Societies Provide Support for Citizens to Maintain Their Good Health 3.
Environmental Health III. Epidemiology Shu-Chi Chang, Ph.D., P.E., P.A. Assistant Professor 1 and Division Chief 2 1 Department of Environmental Engineering.
Healthy Ageing Research – Developments and Lessons By Hal Kendig Faculty of Health Sciences University of Sydney National Symposium on Ageing Research.
Security of Computerized Medical Information: Threats from Authorized Users James G. Anderson, Ph.D. Purdue University.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.
Informed Consent and HIPAA Tim Noe Coordinating Center.
Management of Communication and Information Chapter -MCI
Risk management planning related to Health Information Technology
Tasks and responsibilities of the German organ procurement organization DSO Technical Assistance for Alignment in Organ Donation 1st International Symposium.
Managing Education Quality & Commissioning in a Local Education & Training Board System Peter Rolland Head of Education Commissioning & Contracting
Research Methods for the Social Sciences: Ethics Ryan J. Martin, Ph.D. Thomas N. Cummings Research Fellow March 9, 2010.
Health Sciences.  Principles  Code of Conduct for right and wrong  Values  Core of all health care decisions.
ELECTRONIC HEALTH RECORD
Is this Research? Exempt? Expedited?
Victoria E. Aldridge, Pharm.D. JUSTIFICATION OF CLINICAL STAFFING Victoria E. Aldridge, Pharm.D.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Patient Information Recall Systems. Learning objectives Understand the link between population health data and chronic disease care Know what information.
Results from eHI & CHIME Survey Use of Data and Analytics by Providers Jennifer Covich Chief Executive Officer August 30, 2012.
Electronic Health Records Dimitar Hristovski, Ph.D. Institute of Biomedical Informatics.
Confidentiality and Security Issues in ART & MTCT Clinical Monitoring Systems Meade Morgan and Xen Santas Informatics Team Surveillance and Infrastructure.
1 Healthcare Privacy and Security: Concepts and Challenges Dixie B. Baker, Ph.D. Chair, HIMSS Privacy and Security Advocacy Task Force.
Conducting Research in the UK National Health Service Dr Stephen Brett Reader In Critical Care.
Implementing universal Lynch Syndrome screening in a large healthcare system.
Implications for the Use of Tissue in Research P. Pearl O’Rourke, MD Partners HealthCare Boston, MA.
European Standards on Confidentiality and Privacy in Healthcare Dr Colin M Harper Division of Psychiatry & Neuroscience Queen’s University.
0 Craig Miller Vice President, Health Strategy and Innovation Health Information Exchange: Facilitating data sharing between public.
Steps in Preparing a Business Plan. Preliminary Step Must have a decision making apparatus in place –Governing Board –Viable committee structure Operations.
Security of the Distributed Electronic Patient Record: A Case-Based Approach James G. Anderson, Ph.D. Purdue University.
Networking and Health Information Exchange Unit 6b EHR Functional Model Standards.
Ethical and Regulatory Considerations in Research using Residual Specimens Jeffrey R. Botkin, M.D., M.P.H. Professor of Pediatrics and Medical Ethics Associate.
Final UNDERSTANDING CONFIDENTIALITY Training Overview by Jolynn Rogers.
Contracting Decision Criteria Study Group Members/Associates: Representatives of State Agencies (DAS, Revenue, Judicial, Justice, Transportation), Private.
D.Zucker Draft-EB09 Ethics & Academic Technology Transfer: Patients, Products and Public Trust Deborah Zucker, MD, PhD, Tufts Medical Center.
The Paradox in HIPAA Deven McGraw, JD, MPH, LLM Partner Manatt, Phelps & Phillips, LLP December 8, 2014.
MPOG study overview Anesthesia mortality: –1/5,000 in 1950 –1/200,000 in 2008 Significant morbidity for RARE events –Renal Failure, Myocardial Infarction,
The Culture of Healthcare Privacy, Confidentiality, and Security Lecture d This material (Comp2_Unit9d) was developed by Oregon Health and Science University,
Prognostic models in the ICU From development to clinical practice L. Minne, MSc. Dr. S. Eslami, PharmD Dr. D.A. Dongelmans, MD Prof. Dr. S.E.J.A. de Rooij,
June 24, 2003 Health Communications Progress Review Focus Area 11.
Integrating a Federated Healthcare Data Query Platform With Electronic IRB Information Systems Shan He IPHIE 2010.
Community Quality Collaboratives: Accomplishments, Challenges and Opportunities Gary J. Young, J.D., Ph.D. Director and Professor Center for Health Policy.
Nursing Informatics NI.
Critical Appraisal (CA) I Prepared by Dr. Hoda Abd El Azim.
This material was developed by Duke University, funded by the Department of Health and Human Services, Office of the National Coordinator for Health Information.
APPROVAL CRITERIA AN IRB INFOSHORT MAY CFR CRITERIA FOR IRB APPROVAL OF RESEARCH In order for an IRB to approve a research study, all.
Regulations 201: Thorny Issues What is Research? Exempt and Expedited Reviews.
This material was developed by Oregon Health & Science University, funded by the Department of Health and Human Services, Office of the National Coordinator.
Results Providers (n=20) were more willing to share patient data when: Sharing with universities vs. private firms and non-government organizations No.
Summary of the 2013 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2015.
The U. S. Health Care System Challenges, Opportunities and Solutions Fifth National HIPAA Summit Clinical Data Standards and the Creation of an Interconnected,
What has been the most common difficulty for you when implementing a digital project?
Quality Control Dr. Waddah D’emeh. Controlling Fifth and final step of the management process. Performance is measured against predetermined standards.
Human Research Protection Program 101 March 20, 2007 Cincinnati, OH.
Management Information System In Healthcare
The Medical College of Georgia HIPAA Privacy Rule Orientation.
New Hire HIPAA Orientation. HIPAA Overview HIPAA is an acronym that stands for the Health Insurance Portability and Accountability Act of HIPAA.
FERPA & HIPAA: Maintaining Student Confidentiality.
Phone a Friend Who’s Who in Healthcare. Support Functions Report to the Executive Office –Strategic planning –Financial –Information –Human Resources.
Contra Costa County Sustainability Audit
Patricia M. Alt, Ph.D. Dept. of Health Science Towson University
Jeopardy Final Jeopardy Chapter 1 Chapter 2 Chapter 11 Chapter 12 $100
Presentation transcript:

Challenges and Opportunities for Data Reuse Ronald Cornet, PhD Dept. of Medical Informatics Academic Medical Center – University of Amsterdam

Overview  Why Data Reuse  Categories of Data Reuse  Challenges  Opportunities

Data Reuse  Many data are collected in the care process  Many data are needed e.g., for research purposes  Two options:  Dedicated collection of purpose-specific data  Re-using data from the care process

Dedicated Data Collection  Allows for optimally defined data set  But…  May lead to redundant data collection  Can not always be performed (e.g., retrospectively)

Re-using Data from Care Process  Benefits from readily available data  But…  Data may be incomplete  Data may lack detail  Data may be biased  Data may be incomparable

Seeking a balance  Data from the clinical care process often not fit for reuse  Dedicated data collection costly or impossible  Recording “everything” about “everyone” is impossible  How to collect data in the primary care process that can be reused with minimal drawbacks (e.g., bias, detail)?

Example – cost analysis  Cost analysis based on care records  Only recorded care is taken into account for cost analysis  E.g., during a busy night, a severely traumatized patient enters emergency department, receives blood, resuscitation, and dies, is transported to morgue; no record created

Secondary Uses and Re-uses of Data  Protect and enhance public health  Develop security and confidentiality algorithms and test de-identification routines  Conduct research  Create and maintain terminology and representation formalisms

Secondary Uses and Re-uses (II)  Develop and apply decision support for health care providers  Support quality of patient care  Improve patient safety  Manage personal health

Secondary Uses and Re-uses (III)  Educate and credential healthcare providers and assess training activities  Analyze and Manage Finances  Detect fraud and illicit activity  Identify markets and promote sales

Examples  Public health E.g., setting up disease-specific registries  Cardiosurgery  Renal Failure  Intensive Care  Research E.g., development of prognostic models

Examples  Decision support E.g., develop algorithms, rules, and alerts  Quality of patient care  Manage quality and outcomes »More on this tomorrow (Dr. De Keizer)  Manage staffing and resources  Develop and assess quality indicators

Factors influencing Authorization for secondary Use (I)  Identification Status: Patient identifiable, de- identified, anonymized  Consent provided at the time of data collection  Demographic representation, e.g., age, race, gender  Focus on a vulnerable population (e.g., prisoners)  Original collector and aggregator of the data (government, private)

Factors influencing Authorization for secondary Use (II)  Proposed secondary user of the data, e.g., government, academic institution  Funding source for secondary use  Financial compensation to data collector for providing data to a second party  Beneficiary of secondary use, e.g., society, researcher, academic institution  Disclosure of secondary use, e.g., public disclosure of results and/or methods

 ERA-EDTA Registry  Data about patients on End-Stage Renal Failure  Patient data recorded in renal centers  Data from centers to national registries  Data from national registries to ERA-EDTA  ERA-EDTA shares outcomes with USRDS, ANZDATA Data Reuse Case StudyData Re-Re-Reuse Case Study

Challenges

Opportunities  Adjust data to the intended reuse or  Adjust the intended reuse to the data

Conclusion

Round-up  There are many kinds of data reuse

More information